What is the difference between the codes for congenital hemangiomas ( 17106 - 17108 ), the codes for inflammatory skin disease (eg, psoriasis) ( 96920 - 96922 ), and the codes for laser destruction ( 17110 - 17111 )? ...
Subscribe or sign in to view the full article.
Article Overview
This article is a coding clarification focused on laser treatment reporting across multiple CPT code series. It compares coding for benign cutaneous vascular proliferative lesions, inflammatory skin disease such as psoriasis, and benign lesion destruction, and it highlights how the relevant guidance changed across different years. The material is aimed at coders and billing staff who need to understand which broad treatment category applies and how reporting is structured at a high level.
Why This Topic Matters
Choosing the correct code family affects whether the service is reported as treatment of a vascular lesion, an inflammatory skin condition, or benign lesion destruction. The article is useful for avoiding confusion between similar laser procedures and for understanding the scope and reporting basis of each code series.
Article Sections
-
Overview of the code series
Introduces the three laser-related coding groups discussed in the article and frames the comparison between them.
-
2003 introduction of the psoriasis laser codes
Summarizes the addition of a new laser treatment series in the Medicine section and its relationship to other laser destruction codes.
-
2007 revision of the benign lesion destruction codes
Describes later changes affecting the reporting scope of the benign lesion destruction code family.
-
Codes specific to cutaneous vascular proliferative lesions
Explains the subset of codes tied to benign cutaneous vascular proliferative lesions and their reporting structure.
-
Examples of conditions not reported with these codes
Lists examples of lesion types or skin findings that are not appropriate for the vascular lesion code series.
What You Will Learn
- How the article differentiates among laser treatment code families
- Which broad clinical categories are associated with each code series
- What annual revisions affected the scope of the benign lesion destruction codes
- How the reporting structure is organized for treated areas or lesion counts
- Which general types of conditions are referenced as outside the intended scope of one code family
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Revenue cycle professionals
- Dermatology practice staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com